Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Affect Consciousness (AC) as an Integrated add-on Component in Mentalization-based Group Treatment for Patients With Personality Disorder (PD)- a Mixed Method Explorative Study.

NCT06983002 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.

NCT NCT06983002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06983002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Affect Consciousness (AC) as an Integrated add-on Component in Mentalization-based Group Treatment for Patients With Personality Disorder (PD)- a Mixed Method Explorative Study.
Lead sponsor
Helse Stavanger HF
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 19, 2025
Completion date
April 19, 2035
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

affect consciousness, mentalization, personality disorder, personality disorder, avoidant, personality disorder, borderline, personality trait, personality type, ptsd, ptsd - post traumatic stress disorder, ptsd and trauma-related symptoms, reflective functioning